Zhou, X;
Chen, Y;
Mok, KY;
Kwok, TCY;
Mok, VCT;
Guo, Q;
Ip, FC;
... Furst, AJ; + view all
(2019)
Non-coding variability at the APOE locus contributes to the Alzheimer's risk.
Nature Communications
, 10
, Article 3310. 10.1038/s41467-019-10945-z.
Preview |
Text
Hardy_Non-coding variability at the APOE locus contributes to the Alzheimer's risk_VoR.pdf - Published Version Download (2MB) | Preview |
Abstract
Alzheimer’s disease (AD) is a leading cause of mortality in the elderly. While the coding change of APOE-ε4 is a key risk factor for late-onset AD and has been believed to be the only risk factor in the APOE locus, it does not fully explain the risk effect conferred by the locus. Here, we report the identification of AD causal variants in PVRL2 and APOC1 regions in proximity to APOE and define common risk haplotypes independent of APOE-ε4 coding change. These risk haplotypes are associated with changes of AD-related endophenotypes including cognitive performance, and altered expression of APOE and its nearby genes in the human brain and blood. High-throughput genome-wide chromosome conformation capture analysis further supports the roles of these risk haplotypes in modulating chromatin states and gene expression in the brain. Our findings provide compelling evidence for additional risk factors in the APOE locus that contribute to AD pathogenesis.
| Type: | Article |
|---|---|
| Title: | Non-coding variability at the APOE locus contributes to the Alzheimer's risk |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1038/s41467-019-10945-z |
| Publisher version: | https://doi.org/10.1038/s41467-019-10945-z |
| Language: | English |
| Additional information: | This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neurodegenerative Diseases |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10082333 |
Archive Staff Only
 |
View Item |
